Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00049764
Recruitment Status : Completed
First Posted : November 14, 2002
Last Update Posted : November 20, 2007
Information provided by:
Eli Lilly and Company